Delivery Order SPE2DB20D1004-SPE2DB24FNCFF

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,927.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Sumatriptan 6 mg/0.5 mL autoinjectors. The contract has an ultimate completion date of November 25, 2024 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) awarded a $2,422.04 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,565,840,056 units of Sumatriptan 6 mg/0.5 mL autoinjectors. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and Amerisourcebergen, which provides a comprehensive range of medical commodities to support military treatment programs and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sumatriptan 6 mg/0.5 mL autoinjector medical supplies. The $1,535.58 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a range of pharmaceutical products and medical supplies to support military healthcare...
This is a $7,440.12 delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Sumatriptan 6 mg/0.5 ml autoinjectors to support military healthcare programs. The contract is a firm fixed-price delivery order that runs through January 27, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,464.47, is for the delivery of sumatriptan 6 mg/0.5 ml autoinjectors. This is a firm fixed-price delivery order contract with a completion date of May 23, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor and there is no mention of major subcontractors. This...
This federal contract award, valued at $1,822.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Sumatriptan 6 mg/0.5 ml autoinjectors, a medication used to treat migraine headaches. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Sumatriptan 6 mg/0.5 ml autoinjectors. The $2,909.89 firm-fixed-price contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a wide range of medical commodities to...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,653.88 firm fixed-price delivery order is for the supply of 4,565,752,700 units of the drug Sumatriptan 6 mg/0.5 ml autoinjector. The award has an ultimate completion date of September 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Sumatriptan 6 mg/0.5 ml autoinjectors. The $2,805.76 firm fixed-price contract has a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 2025. This single-award IDC serves as the primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,531,299 units of Sumatriptan 6 mg/0.5 ml autoinjectors. The contract has a ceiling value of $4,285.08 and is a firm fixed price delivery order. The contract has a performance period ending on March 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FNCFF
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,005.11 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Sumatriptan 6 mg/0.5 ml autoinjectors. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 12:40 PM